DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹82.68 | ₹60.38 | ₹68.83 | ₹111.53 | ₹74.75 |
What is the latest Earnings Per Share (EPS) of DIVIS LABORATORIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹82.68 |
| Mar2025 | ₹60.38 |
| Mar2024 | ₹68.83 |
| Mar2023 | ₹111.53 |
| Mar2022 | ₹74.75 |
How is Earnings Per Share (EPS) of DIVIS LABORATORIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹82.68 | 36.93 | |
| Mar2025 | ₹60.38 | -12.28 | |
| Mar2024 | ₹68.83 | -38.29 | |
| Mar2023 | ₹111.53 | 49.20 | |
| Mar2022 | ₹74.75 | - | |
Compare Earnings Per Share (EPS) of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹251,640.9 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
| MANKIND PHARMA | ₹103,286.0 Cr | 9.6% | 1% | -6.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 3.6% |
-1.4% |
37.4% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses